OKAWARA; Bisei

Patent Applications and Registrations

Patent applications and USPTO patent grants for OKAWARA; Bisei.The latest application filed is for "pharmaceutical composition for treating and/or preventing peripheral neuropathy or spinal cord injury".

Company Profile

2.7.11

OKAWARA; Bisei - Yokkaichi-shi JP
Okawara; Bisei - Yokkaichi JP
Okawara; Bisei - Mie JP
OKAWARA; Bisei - Suehiro-Cho JP
Okawara; Bisei - Yokkaichl DE
Okawara; Bisei - Heidelberg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Composition For Treating And/or Preventing Peripheral Neuropathy Or Spinal Cord Injury App 20210106566 - OHNO; Kinji ; et al.	2021-04-15
Rspondins as modulators of angiogenesis and vasculogenesis Grant 10,538,563 - Niehrs , et al. Ja	2020-01-21
Rspondins As Modulators Of Angiogenesis And Vasculogenesis App 20190359664 - Niehrs; Christof ; et al.	2019-11-28
Rspondins as modulators of angiogenesis and vasculogenesis Grant 10,273,276 - Niehrs , et al.	2019-04-30
Pharmaceutical Composition For Treating And/or Preventing Peripheral Neuropathy Or Spinal Cord Injury App 20180271838 - OHNO; Kinji ; et al.	2018-09-27
Receptors Of Rspo2 And Rspo3 App 20170153246 - NIEHRS; Christof ; et al.	2017-06-01
Rspondins As Modulators Of Angiogenesis And Vasculogenesis App 20160009773 - Niehrs; Christof ; et al.	2016-01-14
Antagonist anti-Rspondin3 antibodies Grant 9,226,963 - Niehrs , et al. January 5, 2	2016-01-05
Receptors Of Rspo2 And Rspo3 App 20150362489 - NIEHRS; Christof ; et al.	2015-12-17
Rspondin antibodies as inhibiting factors of angiogenesis and vaculogenesis Grant 8,926,970 - Niehrs , et al. January 6, 2	2015-01-06
Rspondins As Modulators Of Angiogenesis And Vasculogenesis App 20140350226 - Niehrs; Christof ; et al.	2014-11-27
Rspondins As Modulators Of Angiogenesis And Vasculogenesis App 20140056894 - Niehrs; Christof ; et al.	2014-02-27
Rspondin polypeptides as promoting factors of angiogenesis and vasculogenesis Grant 8,580,736 - Niehrs , et al. November 12, 2	2013-11-12
Receptors Of Rspo2 And Rspo3 App 20120263730 - Niehrs; Christof ; et al.	2012-10-18
Rspondins As Modulators Of Angiogenesis And Vasculogenesis App 20120088727 - Niehrs; Christof ; et al.	2012-04-12
Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonists Grant 8,088,374 - Niehrs , et al. January 3, 2	2012-01-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.